FBN1 and skeletal dysplasia: A notable aspect of this study was the frequency of heterozygous mutations detected in genes previously associated with skeletal dysplasia (NPR2, ACAN, CASR, COMP, and FBN1), confirming the dose effect of cartilage matrix proteins in growth and development.